Search

Ashok Purandare Phones & Addresses

  • 79 Manley Rd, Pennington, NJ 08534 (609) 818-1547
  • 79 Maple Ln, Pennington, NJ 08534
  • 2104 Pheasant Hollow Dr, Plainsboro, NJ 08536 (609) 275-1734
  • New Brunswick, NJ
  • Hopewell, NJ
  • Piscataway, NJ
  • Trenton, NJ
  • 79 Manley Rd, Pennington, NJ 08534 (609) 713-4698

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Resumes

Resumes

Ashok Purandare Photo 1

Senior Principal Scientist And Project Leader, Oncology And Immuno-Oncology Chemistry

View page
Location:
Pennington, NJ
Industry:
Pharmaceuticals
Work:
Bristol-Myers Squibb
Senior Principal Scientist and Project Leader, Oncology and Immuno-Oncology Chemistry

Hoechst Ag 1984 - 1986
Research Associate
Education:
Rutgers University 1991 - 1994
Indian Institute of Chemical Technology 1986 - 1991
Doctorates, Doctor of Philosophy, Organic Chemistry
Indian Institute of Technology, Bombay 1982 - 1985
Masters, Organic Chemistry
Department of Technology, Savitribai Phule Pune University 1979 - 1982
Bachelors, Bachelor of Science, Chemistry
Skills:
Medicinal Chemistry
Drug Discovery
Drug Design
Drug Development
Organic Synthesis
Organic Chemistry
Hplc
Nmr
Chemistry
Chromatography
R&D
Pharmaceutical Industry
Lead Change
Lc Ms
Neuroscience
Immunology
Life Sciences
Biotechnology
In Vivo
Purification
Parallel Synthesis
Combinatorial Chemistry
Admet
Prodrug
Cancer
Biochemistry
Pharmacology
Kinase Inhibitors
Epigenetics
Structure Based Drug Design
Matrix Management
Oncology
Languages:
English
Marathi
Hindi
Ashok Purandare Photo 2

Ashok Purandare

View page

Publications

Us Patents

Antagonists Of Chemokine Receptors

View page
US Patent:
7202249, Apr 10, 2007
Filed:
Aug 25, 2003
Appl. No.:
10/648677
Inventors:
Ashok V. Purandare - Pennington NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 471/04
A61K 31/519
A61P 11/06
A61P 19/02
A61P 17/06
US Classification:
51425305, 544279, 544363, 5142641, 51426411
Abstract:
Compounds are provided which are antagonists of chemokine receptor activity. The compounds thereof have the structure.

Pyrrolotriazine Kinase Inhibitors

View page
US Patent:
7531539, May 12, 2009
Filed:
Aug 8, 2007
Appl. No.:
11/835456
Inventors:
Brian E. Fink - Yardley PA, US
Ping Chen - Belle Mead NJ, US
Ashok Vinayak Purandare - Pennington NJ, US
Honghe Wan - Pennington NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 487/04
C07D 403/12
C07D 403/14
A61K 31/53
A61P 19/02
A61P 35/00
US Classification:
514243, 544183
Abstract:
The present invention provides compounds of formula IThe formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

Jak2 Inhibitors And Their Use For The Treatment Of Myeloproliferative Diseases And Cancer

View page
US Patent:
8202881, Jun 19, 2012
Filed:
Sep 2, 2010
Appl. No.:
12/874276
Inventors:
Ashok V. Purandare - Pennington NJ, US
James W. Grebinski - Lawrenceville NJ, US
Amy Hart - Ewing NJ, US
Jennifer Inghrim - Plainsboro NJ, US
Gretchen Schroeder - Ewing NJ, US
Honghe Wan - Pennington NJ, US
Assignee:
Bristol-Meyers Squibb Company - Princeton NJ
International Classification:
A61K 31/437
C07D 471/14
C07D 471/16
US Classification:
514290, 546 82, 546 85, 546 87
Abstract:
The present invention provides compounds of formula I.

Pyrrolotriazine Kinase Inhibitors

View page
US Patent:
8445676, May 21, 2013
Filed:
Oct 8, 2009
Appl. No.:
13/123305
Inventors:
Ashok Vinayak Purandare - Pennington NJ, US
David B. Frennesson - Naugatuck CT, US
Muthoni G. Kamau - Lawrenceville NJ, US
Lalgudi S. Harikrishnan - Skillman NJ, US
Mark G. Saulnier - Higganum CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 487/04
A61K 31/53
A61P 35/00
US Classification:
544183, 514243
Abstract:
The present invention provides compounds of formula IThe formula I compounds inhibit tyrosine kinase activity of such as Jak2 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

5-Ht7 Receptor Antagonists

View page
US Patent:
20020032199, Mar 14, 2002
Filed:
Apr 24, 2001
Appl. No.:
09/841273
Inventors:
Michael Poss - Lawrenceville NJ, US
Ashok Purandare - Pennington NJ, US
Ronald Mattson - Meriden CT, US
Li-Qiang Sun - Glastonbury CT, US
International Classification:
C07D251/54
C07D239/46
A61K031/53
US Classification:
514/245000, 514/272000, 544/196000, 544/323000
Abstract:
Amino-pyrimidine and amino-triazine derivatives having 5-HTantagonist activity for the treatment of sleeping disorders, depression, schizophrenia, anxiety, obsessive compulsive disorders, circadian rhythm disorders, ocular disorders and/or centrally and peripherally mediated hypertension are provided.

Methods For Inhibiting Proteasome

View page
US Patent:
20040171556, Sep 2, 2004
Filed:
Jan 21, 2004
Appl. No.:
10/761990
Inventors:
Ashok Purandare - Pennington NJ, US
Naomi Laing - Stoneham MA, US
International Classification:
A61K031/69
A61K031/4015
US Classification:
514/019000, 514/064000, 514/424000
Abstract:
The present invention relates to methods for inhibiting proteasome comprising administering to mammals in need thereof a compound having Formula I:

Heterocyclic Inhibitors Of Protein Arginine Methyl Transferases

View page
US Patent:
20060235037, Oct 19, 2006
Filed:
Apr 13, 2006
Appl. No.:
11/403790
Inventors:
Ashok Purandare - Pennington NJ, US
Honghe Wan - Pennington NJ, US
Tram Huynh - Pennington NJ, US
International Classification:
A61K 31/4747
A61K 31/46
A61K 31/454
A61K 31/4184
A61K 31/404
C07D 403/02
US Classification:
514278000, 514304000, 514314000, 514337000, 514338000, 546015000, 546125000, 546176000, 546201000, 514394000, 548305400, 548465000, 546199000
Abstract:
A compound of formula I, or a stereoisomer, a tautomer, a pharmaceutically acceptable salt or solvate thereof, methods of using such compounds in the treatment of hyperproliferative, inflammatory, infectious, and immunoregulatory disorders and diseases; and to pharmaceutical compositions containing such compounds.

Inhibitors Of Protein Arginine Methyl Transferases

View page
US Patent:
20070060589, Mar 15, 2007
Filed:
Dec 20, 2005
Appl. No.:
11/312812
Inventors:
Ashok Purandare - Pennington NJ, US
Zhong Chen - Princeton NJ, US
International Classification:
A61K 31/506
A61K 31/501
A61K 31/497
A61K 31/4709
A61K 31/4545
A61K 31/454
C07D 417/02
C07D 413/02
C07D 403/02
US Classification:
514252050, 514310000, 514326000, 514255050, 514256000, 514318000, 544238000, 544333000, 544405000, 546146000, 546194000, 546209000
Abstract:
A compound of formula I, or a stereoisomer, a tautomer, a pharmaceutically acceptable salt or solvate thereof, methods of using such compounds in the treatment of hyperproliferative, inflammatory, infectious, and immunoregulatory disorders and diseases; and to pharmaceutical compositions containing such compounds.
Ashok V Purandare from Pennington, NJ, age ~63 Get Report